Oric Pharmaceuticals (ORIC) Stock: Buy, Sell, or Hold?
ORIC - Oric Pharmaceuticals, Inc. Common Stock
$12.21
-0.31 (-2.52%)
▼
5d:
-7.26%
30d:
-7.04%
90d:
+11.87%
HOLD
MODERATE Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 12, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 1, 2026 at $12.99 · last confirmed Oct 2, 2026
Strength: 7.7/10
Get Alerted When ORIC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ORIC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ORIC shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ORIC is currently trading at $12.21, which is considered slightly low relative to its 30-day fair value range of $12.50 to $13.48.
Technical Outlook: Technically, ORIC is in a strong uptrend. The price is currently testing key support at $12.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ORIC scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $21.08 (+72.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ORIC is in a strong uptrend. The price is currently testing key support at $12.16. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ORIC scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $21.08 (+72.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$12.50 -
$13.48
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 72.7% below Wall St target ($21.08)
- CAUTION: 5-day price weakness (-7.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$12.50 -
$13.48
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$12.17
Resistance Level
$14.12
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.29
Wall Street Target
$21.08
(+72.7%)
Share & Embed Analysis
Last updated: October 03, 2026 1:54 AM ET
Data refreshes hourly during market hours. Next update: 2:54 AM
Data refreshes hourly during market hours. Next update: 2:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ORIC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 66 BUY |
